Using Affected Embryos to Establish Linkage Phase in Preimplantation Genetic Testing for Thalassemia
Overview
Reproductive Medicine
Affiliations
Background: This study aimed to evaluate the ability of next-generation sequencing (NGS) to conduct preimplantation genetic testing (PGT) for thalassemia using affected embryos.
Methods: This study included data from 36 couples who underwent PGT for thalassemia without probands and relative pedigrees. NGS results were compared with prenatal diagnosis results.
Results: Thirty-six couples (29 α-thalassemia and 7 β-thalassemia) underwent 41 PGT cycles (31 α-thalassemia and 10 β-thalassemia). Analysis using NGS produced conclusive results for all biopsied blastocysts (100%, 217/217). One hundred and sixty (73.7%, 160/217) were unaffected by thalassemia. Preimplantation genetic testing for aneuploidy revealed that 112 (70.0%, 112/160) were euploid. Single blastocysts were transferred into the uteri of 34 women (53 frozen embryo transfer [FET] cycles). Thirty-two cycles resulted in clinical pregnancies, with a clinical pregnancy rate of 60.1% (32/53) per FET cycle. Twenty-two cycles (22 couples) resulted in 23 live births, with a live birth rate of 43.4% (23/53; 3 cycles were ongoing pregnancies). All 25 embryos' prenatal diagnosis results and/or thalassemia gene analyses after delivery were concordant with the NGS-PGT results. Seven embryos (21.9%, 7/32) were miscarried before 12 weeks' gestation, and the abortion villus in four showed a normal karyotype and thalassemia results consistent with the NGS-PGT results. Aborted fetus samples from 3 cycles were not available because the pregnancy lasted less than 5 weeks.
Conclusion: NGS can be used to conduct PGT for thalassemia using affected embryos as a reference.
Trial Registration: Retrospectively registered.
Xue J, Xie M, Cai J, Kang K, Gu M, Li M Reprod Biol Endocrinol. 2025; 23(1):34.
PMID: 40038676 PMC: 11881346. DOI: 10.1186/s12958-025-01366-3.
Ren Z, Huang P, Wang Y, Yao Y, Ren J, Xu L J Assist Reprod Genet. 2024; 41(11):3225-3235.
PMID: 39256293 PMC: 11621276. DOI: 10.1007/s10815-024-03240-4.
Lan Y, Zhou H, He S, Shu J, Liang L, Wei H Front Endocrinol (Lausanne). 2024; 14:1176063.
PMID: 38523870 PMC: 10957767. DOI: 10.3389/fendo.2023.1176063.
Zhang P, Zhao X, Li Q, Xu Y, Cheng Z, Yang L Front Mol Biosci. 2024; 11:1329580.
PMID: 38516188 PMC: 10955336. DOI: 10.3389/fmolb.2024.1329580.
Should non-invasive prenatal testing be recommended for patients who achieve pregnancy with PGT?.
Liang Y, Li M, Fei J, Chen Z BMC Pregnancy Childbirth. 2024; 24(1):100.
PMID: 38302865 PMC: 10832195. DOI: 10.1186/s12884-024-06284-7.